Benzonatate

DB00868ApprovedSmall moleculeNon-narcotic Antitussive

Benzonatate is a non-narcotic oral antitussive drug used to suppress coughing. It works to reduce the activity of cough reflex by desensitizing the tissues of the lungs and pleura involved in the cough reflex.

Chemical structure of Benzonatate
Mechanism
Curator reviewed · 7 references
Primary indication
Benzonatate is indicated for the symptomatic relief of cough.Curator reviewed · 1 structured indication
Formula / weight
C30H53NO11 · 603.7419 g/mol (avg)
First approval
United States, 1958
Also known as
Benzononatine
Code names
KM 65

Resolves to

Structure
InChIKeyMAFMQEKGGFWBAB-UHFFFAOYSA-NSMILESCCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
620Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
389Marketed productsAcross 1 country and 88 labellers
Sign in
1ATC codeIncluding every combination product, plus 13 drug categories
Sign in
11+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Benzonatate, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account